Multi-epitope immunopurifications of huntingtin (HTT) from vulnerable brain regions of Huntington’s disease (HD) models ...

The amount of input target protein sample to use depends on the detection limit of the assay, but 10% of the amount added to each binding reaction (3 μl) is usually sufficient. The unbound target ...

研究论文 “Tailored protein corona behavior in titanium dioxide nanosheet fluorescence biosensor for protein quantification assays ...

This article explores how automation is transforming proteomics by streamlining proteoform analysis, boosting throughput and ...

A pure sample of protein is required to generate antibodies, conduct binding assays and study structure. Yet the target protein must first be isolated; the debris, salts and reagents washed away ...

Olink® Reveal is an NGS-based proteomics solution offering high-throughput biomarker analysis with minimal hands-on time.

The global luciferase assay market is set to experience robust growth, with its valuation projected to rise from USD 1,536.70 million in 2024 to USD 3,022.90 million by 2034, registering a CAGR of ...

For the first time, scientists have identified promising drug candidates that bind irreversibly with a notoriously ...

It is heartening that in a significant development in the fight against cancer, researchers have discovered peptides which ...

The anti-melanogenesis effect of ligustroside derived from Ligustrum japonicum and its underlying mechanisms are explored.

A team that includes a RIKEN researcher has refined a lab test for measuring protein aggregate levels in samples from patients with certain neurodegenerative diseases. This has the potential to ...

AliveDx previously gained CE marks for assays including the MosaiQ Centromere Protein B (CENP-B) microarray for the identification of autoantibodies to Centromere Protein B, and MosaiQ AiPlex CD ...